Back to All Events

Signature Series—What’s Next: Clinical Research Innovation

Signature Series Session

Clinical research is undergoing a dynamic transformation—propelled by breakthrough developments, evolving regulations, and fresh approaches to collaboration. In this fast-moving landscape, adaptability and strategic foresight are no longer optional—they’re essential for navigating what’s next.

David Burrow will offer strategic insights on elevating trial quality and minimizing regulatory uncertainty—sharing forward-thinking approaches and practical tools designed to help research professionals thrive in today’s complex and rapidly shifting environment.

Key topics:

  • Emerging trends shaping the future of clinical research

  • Foundational principles of Quality by Design

  • Leveraging the FDA’s CDER Center for Clinical Trial Innovation (C3TI)

  • The growing impact of artificial intelligence on trial design and execution

  • Actionable strategies for navigating periods of rapid change

Whether you're rethinking trial design, exploring new technologies, or seeking clarity in a changing regulatory landscape, you’ll leave this session equipped to lead with purpose and drive meaningful progress in a field that’s redefining what’s possible.

CEU: 1.00 ACRP

Speaker:

Earlier Event: April 27
There's a Better Way to Approach Training for New Clinical Trials Team Members